Medical investigations use a wide variety of outcome indicators that are often not comparable. It can be challenging to integrate results across multiple studies that do not share a common metric. Some conditions such as Duchenne and Becker muscular dystrophy have a predictable course of disease progression. Severity can be inferred from a patient’s medical history. This paper describes the development of a disease severity measure using common markers of disease progression. Rasch modeling was used to estimate severity using dichotomous events that indicate disease progression. Caregivers of 34 young men with Duchenne or Becker muscular dystrophy completed structured interviews about their care and medical history. Interview questions incl...
OBJECTIVES: The objective of this study was to examine the psychometric properties of the Pediatric ...
Dystrophinopathies are caused by mutations in DMD resulting in progressive muscle weakness. They are...
Our study aimed to determine the burden of illness in dystrophinopathy type Duchenne (DMD) and Becke...
Abstract Background Person-reported outcomes measurement development for rare diseases has lagged be...
Background: There is no consensus method for determining progression of disability in patients with ...
BACKGROUND: There is no consensus method for determining progression of disability in patients with ...
Background: There is no consensus method for determining progression of disability in patients with ...
The overall aim of this thesis was to identify outcome measures in Duchenne muscular dystrophy (DMD)...
Muscular dystrophy (MD) comprises a group of diseases characterized by progressive muscle weakness t...
Aim To develop a patient‐reported outcome measure (PROM) assessing upper limb function related to ac...
Objectives: To monitor treatment effects in patients with congenital myopathies and congenital muscu...
Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA) are neuromuscular diseases chara...
Abstract Background In clinical trials for rare diseases, such as Duchenne muscular dystrophy, clini...
International audienceThe Motor Function Measure is a standardized scoring system to evaluate motor ...
Functional variability among boys with Duchenne muscular dystrophy (DMD) is well recognised and comp...
OBJECTIVES: The objective of this study was to examine the psychometric properties of the Pediatric ...
Dystrophinopathies are caused by mutations in DMD resulting in progressive muscle weakness. They are...
Our study aimed to determine the burden of illness in dystrophinopathy type Duchenne (DMD) and Becke...
Abstract Background Person-reported outcomes measurement development for rare diseases has lagged be...
Background: There is no consensus method for determining progression of disability in patients with ...
BACKGROUND: There is no consensus method for determining progression of disability in patients with ...
Background: There is no consensus method for determining progression of disability in patients with ...
The overall aim of this thesis was to identify outcome measures in Duchenne muscular dystrophy (DMD)...
Muscular dystrophy (MD) comprises a group of diseases characterized by progressive muscle weakness t...
Aim To develop a patient‐reported outcome measure (PROM) assessing upper limb function related to ac...
Objectives: To monitor treatment effects in patients with congenital myopathies and congenital muscu...
Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA) are neuromuscular diseases chara...
Abstract Background In clinical trials for rare diseases, such as Duchenne muscular dystrophy, clini...
International audienceThe Motor Function Measure is a standardized scoring system to evaluate motor ...
Functional variability among boys with Duchenne muscular dystrophy (DMD) is well recognised and comp...
OBJECTIVES: The objective of this study was to examine the psychometric properties of the Pediatric ...
Dystrophinopathies are caused by mutations in DMD resulting in progressive muscle weakness. They are...
Our study aimed to determine the burden of illness in dystrophinopathy type Duchenne (DMD) and Becke...